Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease

[1]  C. Gaig,et al.  Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder , 2023, Neurology.

[2]  D. Dolinoy,et al.  Epigenetics and the Exposome: DNA Methylation as a Proxy for Health Impacts of Prenatal Environmental Exposures. , 2023, Exposome.

[3]  Alison I. Bernstein,et al.  Parkinson’s disease-associated, sex-specific changes in DNA methylation at PARK7 (DJ-1), SLC17A6 (VGLUT2), PTPRN2 (IA-2β), and NR4A2 (NURR1) in cortical neurons , 2022, npj Parkinson's Disease.

[4]  A. Schapira,et al.  Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease , 2022, Frontiers in Neurology.

[5]  Z. Qian,et al.  Ambient air pollution, lifestyle, and genetic predisposition associated with type 2 diabetes: Findings from a national prospective cohort study. , 2022, The Science of the total environment.

[6]  D. Sulzer,et al.  Similarities and differences between nigral and enteric dopaminergic neurons unravel distinctive involvement in Parkinson’s disease , 2022, NPJ Parkinson's disease.

[7]  H. Fröhlich,et al.  Epigenome-Wide Analysis of DNA Methylation in Parkinson’s Disease Cortex , 2022, Life.

[8]  S. Papageorgiou,et al.  Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review , 2022, Brain sciences.

[9]  D. Hernandez,et al.  Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study , 2022, Movement disorders : official journal of the Movement Disorder Society.

[10]  L. Leclair-Visonneau,et al.  Gastrointestinal mucosal biopsies in Parkinson’s disease: beyond alpha-synuclein detection , 2021, Journal of Neural Transmission.

[11]  E. Dorsey,et al.  Preventing Parkinson’s Disease: An Environmental Agenda , 2021, Journal of Parkinson's disease.

[12]  A. Nott,et al.  CHAS, a deconvolution tool, infers cell type-specific signatures in bulk brain histone acetylation studies of brain disorders , 2021 .

[13]  B. Dickerson,et al.  Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses , 2021, medRxiv.

[14]  B. Kim,et al.  Association of NO2 and Other Air Pollution Exposures With the Risk of Parkinson Disease. , 2021, JAMA neurology.

[15]  O. Tysnes,et al.  Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain , 2021, Molecular Neurodegeneration.

[16]  O. Tysnes,et al.  Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain , 2021, Molecular Neurodegeneration.

[17]  R. Caselli,et al.  DNA Methylation and Expression Profiles of Whole Blood in Parkinson’s Disease , 2021, Frontiers in Genetics.

[18]  Yanru Huang,et al.  The role of DNA methylation in syndromic and non-syndromic congenital heart disease , 2021, Clinical epigenetics.

[19]  S. Horvath,et al.  DNA methylation biomarker for cumulative lead exposure is associated with Parkinson’s disease , 2021, Clinical epigenetics.

[20]  G. Castelo-Branco,et al.  Single-cell CUT&Tag profiles histone modifications and transcription factors in complex tissues , 2021, Nature Biotechnology.

[21]  F. Lohoff,et al.  Epigenetics of alcohol use disorder—A review of recent advances in DNA methylation profiling , 2021, Addiction biology.

[22]  C. Glass,et al.  Nuclei isolation of multiple brain cell types for omics interrogation , 2021, Nature Protocols.

[23]  Maite Huarte,et al.  Gene regulation by long non-coding RNAs and its biological functions , 2020, Nature reviews. Molecular cell biology.

[24]  P. Demers,et al.  Neurodegenerative diseases among miners in Ontario, Canada, using a linked cohort , 2020, Occupational and Environmental Medicine.

[25]  Howard Y. Chang,et al.  Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer’s and Parkinson’s diseases , 2020, Nature Genetics.

[26]  M. Toth.  Epigenetic Neuropharmacology: Drugs Affecting the Epigenome in the Brain. , 2020, Annual review of pharmacology and toxicology.

[27]  B. Garcia,et al.  An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer’s disease , 2020, Nature Genetics.

[28]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[29]  C. Dani,et al.  Effect of exercise and grape juice on epigenetic modulation and functional outcomes in PD: A randomized clinical trial , 2020, Physiology & Behavior.

[30]  Roderic L. Jones,et al.  Using low-cost sensor technologies and advanced computational methods to improve dose estimations in health panel studies: results of the AIRLESS project , 2020, Journal of Exposure Science & Environmental Epidemiology.

[31]  M. Tiirikainen,et al.  Genome-wide epigenetic analyses in Japanese immigrant plantation workers with Parkinson’s disease and exposure to organochlorines reveal possible involvement of glial genes and pathways involved in neurotoxicity , 2020, BMC Neuroscience.

[32]  Jie Zhang,et al.  Epigenetic Basis of Lead-Induced Neurological Disorders , 2020, International journal of environmental research and public health.

[33]  A. Teschendorff,et al.  EPISCORE: cell type deconvolution of bulk tissue DNA methylomes from single-cell RNA-Seq data , 2020, Genome Biology.

[34]  M. Tiirikainen,et al.  Genome-wide epigenetic analyses in Japanese immigrant plantation workers with Parkinson’s disease and exposure to organochlorines reveal possible involvement of glial genes and pathways involved in neurotoxicity , 2020, BMC Neuroscience.

[35]  C. Bai,et al.  The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis , 2020, Nutrients.

[36]  Zhaohui S. Qin,et al.  DeconPeaker, a Deconvolution Model to Identify Cell Types Based on Chromatin Accessibility in ATAC-Seq Data of Mixture Samples , 2020, Frontiers in Genetics.

[37]  K. Pang,et al.  Biological links between traumatic brain injury and Parkinson’s disease , 2020, Acta Neuropathologica Communications.

[38]  Andreas R. Pfenning,et al.  Cell type-specific histone acetylation profiling of Alzheimer’s disease subjects and integration with genetics , 2020, bioRxiv.

[39]  L. Calderón-Garcidueñas,et al.  Reduced repressive epigenetic marks, increased DNA damage and Alzheimer's disease hallmarks in the brain of humans and mice exposed to particulate urban air pollution. , 2020, Environmental research.

[40]  Mohammad Ziaul Islam Chowdhury,et al.  Variable selection strategies and its importance in clinical prediction modelling , 2020, Family Medicine and Community Health Journal.

[41]  B. D. De Miranda,et al.  Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson's disease. , 2020, Environmental science. Processes & impacts.

[42]  O. Davis,et al.  The association of DNA methylation with body mass index: distinguishing between predictors and biomarkers , 2019, Clinical Epigenetics.

[43]  B. Tang,et al.  Genetic analysis of DNA methylation and hydroxymethylation genes in Parkinson's disease , 2019, Neurobiology of Aging.

[44]  Sonja W. Scholz,et al.  Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies , 2019, The Lancet Neurology.

[45]  James B. Brewer,et al.  Brain cell type–specific enhancer–promoter interactome maps and disease-risk association , 2019, Science.

[46]  S. Berger,et al.  ALCOHOL METABOLISM CONTRIBUTES TO BRAIN HISTONE ACETYLATION , 2019, Nature.

[47]  F. Milagro,et al.  Epigenetic Modifications as Outcomes of Exercise Interventions Related to Specific Metabolic Alterations: A Systematic Review , 2019, Lifestyle Genomics.

[48]  C. Carlsten,et al.  Air pollution and DNA methylation: effects of exposure in humans , 2019, Clinical Epigenetics.

[49]  Fei Zou,et al.  SCDC: bulk gene expression deconvolution by multiple single-cell RNA sequencing references , 2019, bioRxiv.

[50]  E. Heard,et al.  Advances in epigenetics link genetics to the environment and disease , 2019, Nature.

[51]  W. V. van IJcken,et al.  Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes , 2019, Nature Neuroscience.

[52]  S. Horvath,et al.  Longitudinal Epigenome-Wide Methylation Study of Cognitive Decline and Motor Progression in Parkinson's Disease. , 2019, Journal of Parkinson's disease.

[53]  J. Mill,et al.  Guidance for DNA methylation studies: statistical insights from the Illumina EPIC array , 2019, BMC Genomics.

[54]  C. Ling,et al.  Epigenetics in Human Obesity and Type 2 Diabetes , 2019, Cell metabolism.

[55]  Devin C. Koestler,et al.  pwrEWAS: a user-friendly tool for comprehensive power estimation for epigenome wide association studies (EWAS) , 2019, BMC Bioinformatics.

[56]  C. Tanner,et al.  Concordance for Parkinson's disease in twins: A 20‐year update , 2019, Annals of neurology.

[57]  T. Dunckley,et al.  DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood , 2019, Epigenetics.

[58]  R. Marioni,et al.  An epigenetic score for BMI based on DNA methylation correlates with poor physical health and major disease in the Lothian Birth Cohort , 2019, International Journal of Obesity.

[59]  U. Wüllner,et al.  5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson’s disease , 2019, Journal of Chemical Neuroanatomy.

[60]  A. Pisani,et al.  Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence , 2019, Front. Neurol..

[61]  J. Potash,et al.  Genome-wide DNA methylation comparison between live human brain and peripheral tissues within individuals , 2019, Translational Psychiatry.

[62]  Hunna J. Watson,et al.  Genetic Identification of Cell Types Underlying Brain Complex Traits Yields Novel Insights Into the Etiology of Parkinson’s Disease , 2019, bioRxiv.

[63]  B. Bloem,et al.  The Emerging Evidence of the Parkinson Pandemic , 2018, Journal of Parkinson's disease.

[64]  Alison I. Bernstein,et al.  Developmental Dieldrin Exposure Alters DNA Methylation at Genes Related to Dopaminergic Neuron Development and Parkinson’s Disease in Mouse Midbrain , 2018, bioRxiv.

[65]  J. Stock,et al.  Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB , 2018, Proceedings of the National Academy of Sciences.

[66]  S. Horvath,et al.  Organophosphate pesticide exposure and differential genome-wide DNA methylation. , 2018, The Science of the total environment.

[67]  P. Monsivais,et al.  Estimated Residential Exposure to Agricultural Chemicals and Premature Mortality by Parkinson’s Disease in Washington State , 2018, International journal of environmental research and public health.

[68]  B. Reisfeld,et al.  Paraquat exposure and Parkinson’s disease: A systematic review and meta-analysis , 2018, Archives of environmental & occupational health.

[69]  B. Racette,et al.  β2‐adrenoreceptor medications and risk of Parkinson disease , 2018, Annals of neurology.

[70]  S. Beck,et al.  A histone acetylome-wide association study of Alzheimer’s disease identifies disease-associated H3K27ac differences in the entorhinal cortex , 2018, Nature Neuroscience.

[71]  X. Fang,et al.  Association of Levels of Physical Activity With Risk of Parkinson Disease , 2018, JAMA network open.

[72]  N. Gronich,et al.  β2‐adrenoceptor agonists and antagonists and risk of Parkinson's disease , 2018, Movement disorders : official journal of the Movement Disorder Society.

[73]  Peng Li,et al.  Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease , 2018, Medicine.

[74]  Nilanjan Chatterjee,et al.  Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits , 2018, Nature Genetics.

[75]  B. Nordestgaard,et al.  Plasma urate and risk of Parkinson's disease: A mendelian randomization study , 2018, Annals of neurology.

[76]  Seung‐Mo Hong,et al.  Relation of Enteric α-Synuclein to Gastrointestinal Dysfunction in Patients With Parkinson’s Disease and in Neurologically Intact Subjects , 2018, Journal of neurogastroenterology and motility.

[77]  L. Trudeau,et al.  On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease , 2018, Front. Neurol..

[78]  K. Yaffe,et al.  Mild TBI and risk of Parkinson disease , 2018, Neurology.

[79]  H. Adami,et al.  Body mass index, sitting time, and risk of Parkinson disease , 2018, Neurology.

[80]  Miaomiao Han,et al.  Regulatory Roles of Histone Deacetylases 1 and 2 in Pb-induced Neurotoxicity , 2018, Toxicological sciences : an official journal of the Society of Toxicology.

[81]  I. Baldi,et al.  Pesticide use in agriculture and Parkinson's disease in the AGRICAN cohort study. , 2018, International journal of epidemiology.

[82]  T. Chakrabarti,et al.  Manganese exposure: Linking down-regulation of miRNA-7 and miRNA-433 with α-synuclein overexpression and risk of idiopathic Parkinson's disease. , 2018, Toxicology in vitro : an international journal published in association with BIBRA.

[83]  Christoph Ziegenhain,et al.  powsimR: Power analysis for bulk and single cell RNA-seq experiments , 2017, bioRxiv.

[84]  Manolis Kellis,et al.  Chromatin-state discovery and genome annotation with ChromHMM , 2017, Nature Protocols.

[85]  Frank Dudbridge,et al.  Estimation of a significance threshold for epigenome‐wide association studies , 2017, Genetic epidemiology.

[86]  S. Horvath,et al.  Parkinson’s disease is associated with DNA methylation levels in human blood and saliva , 2017, Genome Medicine.

[87]  A. Puschmann.  New Genes Causing Hereditary Parkinson’s Disease or Parkinsonism , 2017, Current Neurology and Neuroscience Reports.

[88]  Molin Wang,et al.  Intake of dairy foods and risk of Parkinson disease , 2017, Neurology.

[89]  Xiang Gao,et al.  Nicotine from cigarette smoking and diet and Parkinson disease: a review , 2017, Translational Neurodegeneration.

[90]  M. Behrens,et al.  On the Role of Mining Exposure in Epigenetic Effects in Parkinson’s Disease , 2017, Neurotoxicity Research.

[91]  Ramón Cacabelos,et al.  Parkinson’s Disease: From Pathogenesis to Pharmacogenomics , 2017, International journal of molecular sciences.

[92]  S. Horvath,et al.  Coffee consumption is associated with DNA methylation levels of human blood , 2017, European Journal of Human Genetics.

[93]  Yoon-Seong Kim,et al.  Hypomethylation of intron1 of α-synuclein gene does not correlate with Parkinson’s disease , 2017, Molecular Brain.

[94]  F. Shephard,et al.  Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease , 2017, npj Parkinson's Disease.

[95]  Lianne Sheppard,et al.  Dose-dependent progression of parkinsonism in manganese-exposed welders , 2017, Neurology.

[96]  Erika P. Raven,et al.  Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson’s disease , 2017, npj Parkinson's Disease.

[97]  T. Chakrabarti,et al.  Global DNA methylation profiling of manganese-exposed human neuroblastoma SH-SY5Y cells reveals epigenetic alterations in Parkinson’s disease-associated genes , 2016, Archives of Toxicology.

[98]  A. Ascherio,et al.  The epidemiology of Parkinson's disease: risk factors and prevention , 2016, The Lancet Neurology.

[99]  Timothy J. Peters,et al.  Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling , 2016, Genome Biology.

[100]  Paul E Brennan,et al.  Chemical probes and inhibitors of bromodomains outside the BET family† †The authors declare no competing interests. , 2016, MedChemComm.

[101]  D. J. Rademacher,et al.  Histone H3 acetylation in the postmortem Parkinson’s disease primary motor cortex , 2016, Neuroscience Letters.

[102]  Robert L. Sielken,et al.  Association between Parkinson’s Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis , 2016, PloS one.

[103]  Xiang Gao,et al.  Prospective study of plasma urate and risk of Parkinson disease in men and women , 2016, Neurology.

[104]  L. Liang,et al.  Genome-Wide Analysis of DNA Methylation and Cigarette Smoking in a Chinese Population , 2016, Environmental health perspectives.

[105]  G. Salvesen,et al.  Regulation of Histone Acetylation by Autophagy in Parkinson Disease* , 2015, The Journal of Biological Chemistry.

[106]  J. Mill,et al.  Interindividual methylomic variation across blood, cortex, and cerebellum: implications for epigenetic studies of neurological and neuropsychiatric phenotypes , 2015, Epigenetics.

[107]  O. Raaschou-Nielsen,et al.  Traffic-Related Air Pollution and Parkinson’s Disease in Denmark: A Case–Control Study , 2015, Environmental health perspectives.

[108]  A. Nordström,et al.  Depression and subsequent risk of Parkinson disease , 2015, Neurology.

[109]  Aleksandra A. Kolodziejczyk,et al.  The technology and biology of single-cell RNA sequencing. , 2015, Molecular cell.

[110]  Jordana T Bell,et al.  Power and sample size estimation for epigenome-wide association scans to detect differential DNA methylation , 2015, International journal of epidemiology.

[111]  L. Sheppard,et al.  Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders. , 2015, Parkinsonism & related disorders.

[112]  S. Balasubramanian,et al.  5-Hydroxymethylcytosine is a predominantly stable DNA modification. , 2014, Nature chemistry.

[113]  P. Sachdev,et al.  DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E In Vitro , 2014, Movement disorders : official journal of the Movement Disorder Society.

[114]  Lana X Garmire,et al.  Power analysis and sample size estimation for RNA-Seq differential expression , 2014, RNA.

[115]  T. Larson,et al.  Mortality study of civilian employees exposed to contaminated drinking water at USMC Base Camp Lejeune: a retrospective cohort study , 2014, Environmental Health.

[116]  O. Stegle,et al.  Single-Cell Genome-Wide Bisulfite Sequencing for Assessing Epigenetic Heterogeneity , 2014, Nature Methods.

[117]  K. Shannon,et al.  Gut feelings about smoking and coffee in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[118]  Chuong B. Do,et al.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.

[119]  K. Iwamoto,et al.  Comprehensive DNA methylation and hydroxymethylation analysis in the human brain and its implication in mental disorders , 2014, Neuropharmacology.

[120]  J. Vlaanderen,et al.  A Case-Control Study of the Protective Effect of Alcohol, Coffee, and Cigarette Consumption on Parkinson Disease Risk: Time-Since-Cessation Modifies the Effect of Tobacco Smoking , 2014, PloS one.

[121]  R. Irizarry,et al.  Accounting for cellular heterogeneity is critical in epigenome-wide association studies , 2014, Genome Biology.

[122]  I. Derrington,et al.  Detection and mapping of 5-methylcytosine and 5-hydroxymethylcytosine with nanopore MspA , 2013, Proceedings of the National Academy of Sciences.

[123]  S. Balasubramanian,et al.  A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation , 2013, Genome Biology.

[124]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[125]  Howard Y. Chang,et al.  Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position , 2013, Nature Methods.

[126]  M. Etminan,et al.  Head injury and risk of Parkinson disease: A systematic review and meta‐analysis , 2013, Movement disorders : official journal of the Movement Disorder Society.

[127]  D. Galasko,et al.  Distinctive patterns of DNA methylation associated with Parkinson disease , 2013, Epigenetics.

[128]  Christian Gieger,et al.  Tobacco Smoking Leads to Extensive Genome-Wide Changes in DNA Methylation , 2013, PloS one.

[129]  Ting Gong,et al.  DeconRNASeq: a statistical framework for deconvolution of heterogeneous tissue samples based on mRNA-Seq data , 2013, Bioinform..

[130]  Martin J. Aryee,et al.  A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression , 2013, Epigenetics.

[131]  N. Heintz,et al.  MeCP2 binds to 5hmc enriched within active genes and accessible chromatin in the nervous system , 2012, Cell.

[132]  J. Olsen,et al.  Parkinson's disease and other neurodegenerative disorders among welders: A Danish cohort study , 2012, Movement disorders : official journal of the Movement Disorder Society.

[133]  Britne A. Shabbott,et al.  Motor control abnormalities in Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.

[134]  C. Tanner,et al.  Solvent exposures and parkinson disease risk in twins , 2012, Annals of neurology.

[135]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[136]  Devin C. Koestler,et al.  DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.

[137]  G. Deuschl,et al.  No evidence for differential methylation of α‐synuclein in leukocyte DNA of Parkinson's disease patients , 2012, Movement disorders : official journal of the Movement Disorder Society.

[138]  U. Wüllner,et al.  Genome-scale methylation analysis of Parkinson's disease patients' brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1 , 2012, neurogenetics.

[139]  M. Fraga,et al.  Epigenetics and the environment: emerging patterns and implications , 2012, Nature Reviews Genetics.

[140]  A. Kanthasamy,et al.  Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration. , 2011, Neurotoxicology.

[141]  E. Masliah,et al.  Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. , 2011, The Journal of biological chemistry.

[142]  S. Tsuji,et al.  CpG Demethylation Enhances Alpha-Synuclein Expression and Affects the Pathogenesis of Parkinson's Disease , 2010, PloS one.

[143]  B. Ritz,et al.  Occurrence of depression and anxiety prior to Parkinson's disease. , 2010, Parkinsonism & related disorders.

[144]  Oliver Kaut,et al.  Methylation Regulates Alpha-Synuclein Expression and Is Decreased in Parkinson's Disease Patients' Brains , 2010, The Journal of Neuroscience.

[145]  A. Kanthasamy,et al.  Environmental Neurotoxic Pesticide Increases Histone Acetylation to Promote Apoptosis in Dopaminergic Neuronal Cells: Relevance to Epigenetic Mechanisms of Neurodegeneration , 2010, Molecular Pharmacology.

[146]  H. Checkoway,et al.  Occupational factors and risk of Parkinson's disease: A population-based case-control study. , 2009, American journal of industrial medicine.

[147]  M. Szyf,et al.  Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology. , 2009, Medical hypotheses.

[148]  C. Tzourio,et al.  Professional exposure to pesticides and Parkinson disease , 2009, Annals of neurology.

[149]  Connie Marras,et al.  Occupation and risk of parkinsonism: a multicenter case-control study. , 2009, Archives of neurology.

[150]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1 , 2009 .

[151]  Hitoshi Takahashi,et al.  The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates , 2007, Neuropathology : official journal of the Japanese Society of Neuropathology.

[152]  M. Weisskopf,et al.  Plasma urate and risk of Parkinson's disease. , 2007, American journal of epidemiology.

[153]  H. Cedar,et al.  Role of DNA Methylation in Stable Gene Repression* , 2007, Journal of Biological Chemistry.

[154]  M. Thun,et al.  Temporal relationship between cigarette smoking and risk of Parkinson disease , 2007, Neurology.

[155]  N. Wood,et al.  Understanding the molecular causes of Parkinson's disease. , 2006, Trends in molecular medicine.

[156]  R. Paffenbarger,et al.  Physical activity and risk of Parkinson’s disease: a prospective cohort study , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[157]  J. Gorell,et al.  Whole-Body Lifetime Occupational Lead Exposure and Risk of Parkinson’s Disease , 2006, Environmental health perspectives.

[158]  B. Weinhold.  Epigenetics: The Science of Change , 2006, Virchows Archiv.

[159]  Eric Jacobs,et al.  Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease , 2005, Annals of neurology.

[160]  Kevin R. Sanft,et al.  Education and occupations preceding Parkinson disease , 2005, Neurology.

[161]  P. Grant,et al.  Effector Proteins for Methylated Histones: An Expanding Family , 2005, Cell cycle.

[162]  Richard J Smeyne,et al.  The MPTP model of Parkinson's disease. , 2005, Brain research. Molecular brain research.

[163]  P. Højrup,et al.  Proteasomal Inhibition by α-Synuclein Filaments and Oligomers* , 2004, Journal of Biological Chemistry.

[164]  V. Uversky,et al.  Nuclear Localization of α-Synuclein and Its Interaction with Histones† , 2003 .

[165]  A. Ascherio,et al.  Caffeinated clues and the promise of adenosine A(2A) antagonists in PD. , 2002, Neurology.

[166]  J. Newell-Price,et al.  DNA Methylation and Silencing of Gene Expression , 2000, Trends in Endocrinology & Metabolism.

[167]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[168]  Richard Ingram,et al.  Power analysis and sample size estimation , 1998 .

[169]  Gregory G. Brown,et al.  Occupational exposures to metals as risk factors for Parkinson's disease , 1997, Neurology.

[170]  C. Marsden,et al.  Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration. , 1996, Biochemical pharmacology.

[171]  D. D. Di Monte,et al.  Comparative studies on the mechanisms of paraquat and 1-methyl-4-phenylpyridine (MPP+) cytotoxicity. , 1986, Biochemical and biophysical research communications.

[172]  J. Goldman,et al.  Lewy bodies of Parkinson's disease contain neurofilament antigens. , 1983, Science.

[173]  Y. Wataya,et al.  Reaction of sodium bisulfite with uracil, cytosine, and their derivatives. , 1970, Biochemistry.

[174]  M. Zigmond,et al.  Exercise: is it a neuroprotective and if so, how does it work? , 2014, Parkinsonism & related disorders.

[175]  Rondi A. Butler,et al.  LINE-1 DNA methylation, smoking and risk of Parkinson's disease. , 2012, Journal of Parkinson's disease.

[176]  V. Uversky,et al.  Nuclear localization of alpha-synuclein and its interaction with histones. , 2003, Biochemistry.